| Health / Medical Topics |
Dual PI3 Kinase/mTOR Inhibitor PKI-587
An agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Upon intravenous administration, PI3K/mTOR kinase inhibitor PKI-587 inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally available agent targeting phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) kinase in the PI3K/mTOR signaling pathway, with…
A dosing unit equal to the amount of active ingredient(s) in a product containing two individual units.
An oral small molecule inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (InsR) tyrosine kinases with potential antineoplastic…
An imaging test that measures bone density (the amount of bone mineral contained in a certain volume of bone) by passing x-rays…
A person with dual diagnosis has both a mental disorder and an alcohol or drug problem. These conditions occur together frequently. In…
A pump system with two enclosed reservoirs, designed to deliver various concentrations of intravenous contrast media.
